166P Evidence-based conclusions and indinations of pemetrexed, taxane and bevacizumab in advanced lung cancer

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	American English
Journal	Journal of Thoracic Oncology
Volume	13
Issue number	4_Suppl
DOIs	https://doi.org/10.1016/s1556-0864(18)30440-4
State	Published - Apr 1 2018

Disciplines

@article{87ac335272144e9999ea5802cc4fdb94,

title = "166P Evidence-based conclusions and indinations of pemetrexed, taxane and bevacizumab in advanced lung cancer",

author = "S. Shaheen and L. Ji and J.W. Morgan and S. Otoukesh and Mirshahidi, \{Hamid R.\}",

year = "2018",

month = apr,

day = "1",

doi = "10.1016/s1556-0864(18)30440-4",

language = "American English",

volume = "13",

journal = "Journal of Thoracic Oncology",

number = "4\_Suppl",

}

TY - JOUR

T1 - 166P Evidence-based conclusions and indinations of pemetrexed, taxane and bevacizumab in advanced lung cancer

AU - Shaheen, S.

AU - Ji, L.

AU - Morgan, J.W.

AU - Otoukesh, S.

AU - Mirshahidi, Hamid R.

PY - 2018/4/1

Y1 - 2018/4/1

UR - https://www.jto.org/article/S1556-0864(18)30440-4/fulltext

U2 - 10.1016/s1556-0864(18)30440-4

DO - 10.1016/s1556-0864(18)30440-4

M3 - Meeting abstract

VL - 13

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 4_Suppl

ER -